A phase II randomized therapeutic optimization trial for patients with refractory metastatic colorectal cancer using circulating tumor DNA (ctDNA): Rapid 1 trial
Rogers, Sherise C., Wang, Shu, Thomas, Ryan Michael, Ramnaraign, Brian Hemendra, Fabregas, Jesus C., Sahin, Ilyas, Staal, Stephen, Murphy, Martina Cathryn, Murillo, Anna Melissa Singson, Markham, Merry Jennifer, Kaye, Frederic J., Heldermon, Coy D., Jones, Dennie V., Close, Julia Lee, Allegra, Carmen Joseph, George, Thomas J.
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Results of a phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response pathway deficient neoplasms
George, Thomas J., Lee, Ji-Hyun, Hosein, Peter Joel, DeRemer, David L., Chatzkel, Jonathan Alexander, Ramnaraign, Brian Hemendra, Rogers, Sherise C., Markham, Merry Jennifer, Daily, Karen Colleen, Ezenwajiaku, Nkiruka, Li, Derek, Murphy, Martina Cathryn, Franke, Aaron J, Staal, Stephen, Close, Julia Lee, Jones, Dennie V., Allegra, Carmen Joseph
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase II randomized therapeutic optimization trial for subjects with refractory metastatic colorectal cancer using circulating tumor DNA (ctDNA): Rapid 1 trial
Rogers, Sherise C., Wang, Shu, Thomas, Ryan Michael, Ramnaraign, Brian Hemendra, Fabregas, Jesus C., Sahin, Ilyas, Staal, Stephen, Murphy, Martina Cathryn, Murillo, Anna Melissa Singson, Markham, Merry Jennifer, Kaye, Frederic J., Heldermon, Coy D., Jones, Dennie V., Dang, Nam H., Close, Julia Lee, George, Thomas J., Allegra, Carmen Joseph
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response (DDR) pathway deficient neoplasms including cholangiocarcinoma
George, Thomas J., DeRemer, David L., Parekh, Hiral D., Lee, Ji-Hyun, Markham, Merry Jennifer, Daily, Karen Colleen, Kaye, Frederic J., Staal, Stephen, Jones, Dennie V., Stechmiller, Bruce K., Allegra, Carmen Joseph, Hromas, Robert A.
Published in Journal of clinical oncology (01.02.2020)
Published in Journal of clinical oncology (01.02.2020)
Get full text
Journal Article
ACTR-29. A PHASE 2 STUDY OF TTFIELDS AND PULSED BEVACIZUMAB IN PATIENTS WITH BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA
Tran, David, Ghiaseddin, Ashley, Campian, Jian, Staal, Stephen, Andrews, Sarah, Warren, Sonisha, Ansstas, George
Published in Neuro-oncology (Charlottesville, Va.) (06.11.2017)
Published in Neuro-oncology (Charlottesville, Va.) (06.11.2017)
Get full text
Journal Article
ATIM-03. TTFIELDS AND PULSED BEVACIZUMAB IN PATIENTS WITH BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA: A PHASE 2 STUDY
Tran, David, Ghiaseddin, Ashley, Campian, Jian, Staal, Stephen, Warren, Sonisha, Allen, Anne, Sampson, Deborah, Greene, Valerie, Ansstas, George
Published in Neuro-oncology (Charlottesville, Va.) (05.11.2018)
Published in Neuro-oncology (Charlottesville, Va.) (05.11.2018)
Get full text
Journal Article
Phase II trial of the PARP inhibitor, niraparib, in BRCA1-Associated Protein 1 (BAP1) and other DNA damage response (DDR) pathway deficient neoplasms including cholangiocarcinoma
George, Thomas J., DeRemer, David L., Lee, Ji-Hyun, Staal, Stephen, Markham, Merry Jennifer, Jones, Dennie V., Hosein, Peter Joel, Daily, Karen Colleen, Chatzkel, Jonathan Alexander, Ramnaraign, Brian Hemendra, Close, Julia Lee, Murphy, Martina Cathryn, Allegra, Carmen Joseph, Rogers, Sherise C., ali, azka, Hromas, Robert A.
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response (DDR) pathway deficient neoplasms (NCT03207347)
ali, azka, DeRemer, David L., Lee, Ji-Hyun, Parekh, Hiral D., Staal, Stephen, Markham, Merry Jennifer, Daily, Karen Colleen, Stechmiller, Bruce K., Jones, Dennie V., Close, Julia Lee, Murphy, Martina Cathryn, Kaye, Frederic J., Allegra, Carmen Joseph, Hromas, Robert A., George, Thomas J.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
The marriage of growth factor inhibitors and chemotherapy: bliss or bust?
Staal, Stephen, O'Connell, Michael J, Allegra, Carmen J
Published in Journal of clinical oncology (01.04.2009)
Published in Journal of clinical oncology (01.04.2009)
Get full text
Journal Article
Hypermethylation of the 5’ Region of the Calcitonin Gene Is a Property of Human Lymphoid and Acute Myeloid Malignancies
Baylin, Stephen B., Fearon, Eric R., Vogelstein, Bert, Bustros, Andree de, Sharkis, Saul J., Burke, Philip J., Staal, Stephen P., Nelkin, Barry D.
Published in Blood (01.08.1987)
Published in Blood (01.08.1987)
Get full text
Journal Article
Large granular lymphocytosis in a patient infected with HTLV-II
Martin, M P, Biggar, R J, Hamlin-Green, G, Staal, S, Mann, D
Published in AIDS research and human retroviruses (01.08.1993)
Published in AIDS research and human retroviruses (01.08.1993)
Get more information
Journal Article